IGLV2-23

Chr 22

immunoglobulin lambda variable 2-23

Also known as: IGLV223, V1-7

Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Jul 2025]

44
ClinVar variants
24
Pathogenic / LP
pLI score
0
Active trials
Clinical SummaryIGLV2-23
📋
ClinVar Variants
24 Pathogenic / Likely Pathogenic· 17 VUS of 44 total submissions

Population Genetics & Constraint

Constraint data not available from gnomAD.

ClinVar Variant Classifications

44 submitted variants in ClinVar

Classification Summary

Pathogenic22
Likely Pathogenic2
VUS17
Likely Benign1
Benign1
Conflicting1
22
Pathogenic
2
Likely Pathogenic
17
VUS
1
Likely Benign
1
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
22
Likely Pathogenic
2
VUS
17
Likely Benign
1
Benign
1
Conflicting
1
Total44

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

IGLV2-23 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype

No OMIM entries found.

Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Top 10 resultsSearch PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →